Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - inhalation powder - 100/6 mcg/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

chiesi usa, inc. - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 0.1 mg in 1 ml - cardene® i.v. (nicardipine hydrochloride) premixed injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable.  for prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see dosage and administration (2.1)] . cardene i.v. premixed injection is contraindicated in patients with advanced aortic stenosis because part of the effect of cardene i.v. premixed injection is secondary to reduced afterload.  reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance. pregnancy category c there are no adequate and well-controlled studies of nicardipine use in pregnant women.  however,  limited human data in pregnant women with preeclampsia or pre-term labor are available.  in animal studies, no embryotoxicity occurred in rats with oral doses 8 times the maximum recommended human dose (mrhd) based on body surface area (mg/m2 ), but did occur in rabbits

Armeenia - inglise - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

chiesi pharmaceuticals gmbh - poractant alfa - suspension endotracheal - 80mg/ml

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - powder for inhalation - 200/6 mcg/acutuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - budesonide, quantity: 3 mg - capsule, modified release - excipient ingredients: sodium lauryl sulfate; iron oxide yellow; tributyl acetylcitrate; colloidal anhydrous silica; titanium dioxide; liquid paraffin; dimeticone 1000; purified talc; iron oxide black; ethylcellulose; gelatin; triethyl citrate; methacrylic acid copolymer; iron oxide red; polysorbate 80; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide; maize starch; sucrose - the induction of remission in adult patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - tobramycin - nebuliser solution - 300/4 milligram(s)/millilitre - other aminoglycosides; tobramycin

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - pressurised inhalation, solution - 100 microgram(s) - glucocorticoids; beclometasone

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - pressurised inhalation, solution - 200 microgram(s) - glucocorticoids; beclometasone

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - pressurised inhalation, solution - 250 microgram(s) - glucocorticoids; beclometasone

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - pressurised inhalation, solution - 50 microgram(s) - glucocorticoids; beclometasone